Mechanisms of infection and fetal adverse effects of Zika virus, Ebola virus, Herpes Simplex virus and Human Papillomavirus infection during pregnancy

Keywords: Viral infection, virus, maternal and fetal immunization, placenta, action mechanism

Abstract

Background. During pregnancy, the immune response of the placenta to viruses and other pathogens plays an important role in determining the vulnerability of a pregnant woman to various infectious diseases such as Zika, Ebola, herpes simplex, and human papilloma. At the maternal-fetal interface, trophoblastic cells, decidual cells, interferons, proteins, and pro-inflammatory molecules serve to minimize and mitigate the spread of viruses between the mother and the developing fetus through a complex system of antiviral immune signaling that involves cellular and molecular responses of maternal-fetal origin. Therefore, the main objective of the present review is to synthesize current information on the effects and mechanisms of action of viral infections during pregnancy. Method. A PubMed, Scopus, Web of Science literature search was performing. We reviewed the experimental studies of in vivo, in vitro and clinical models of viral infections, their adverse effects during pregnancy and the main current treatments published from 2001 to 2020, where each article synthesizes the information on the pregnancy, as well as the cellular mechanisms involved in the mitigation and infection of the different viruses included in this review. Results. A total of 30 articles were included, of which 8 were in vitro studies, 5 in vivo and 7 clinical; the remaining studies corresponded to bibliographic reviews. In general, viral infections during pregnancy were shown to have negative effects on the cardiovascular and central nervous system, in addition to causing premature labor and fetal death in most cases. Inflammatory responses, decidual cells, human antimicrobial cells, intrinsic regulators, proteins, and pro-inflammatory molecules help mitigate the fetal effects of viral infection, as well as secure and protect pregnancy. Conclusion. The placenta and its adjoining decidual cells, as well as the immune system and the gestational stage where the infection occurs, represent important immune components in maternal cellular responses to viral infections, which in turn promote the fetal immune response. However, more studies are still needed to elucidate and clarify the molecular mechanisms involved in viral infection in order to take future actions associated with treatment and prevention during future infections and pandemics.

Downloads

Download data is not yet available.

References

Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G. Viral infections during pregnancy. Am. J. Reprod. Immunol. 2015; 73(3):199-213.

Lee JK, Oh SJ, Park H, Shin OS. Recent Updates on Research Models and Tools to Study Virus-Host Interactions at the Placenta. Viruses. 2019; 12(1):5.

Adams Waldorf KM, McAdams RM. Influence of infection during pregnancy on fetal development. Reproduction. 2013; 146(5):R151-R162.

Kwon JY, Romero R, Mor G. New insights into the relationship between viral infection and pregnancy complications. Am. J. Reprod. Immunol. 2014; 71(5):387-390.

Ticconi C, Pietropolli A, Di Simone N, Piccione E, Fazleabas A. Endometrial Immune Dysfunction in Recurrent Pregnancy Loss. Int. J. Mol. Sci. 2019; 20(21):5332.

Chu HY, Englund JA. Maternal immunization. Clin Infect Dis. 2014; 59(4):560-568.

León-Juárez M, Martínez-Castillo M, González-García LD, et al. Cellular and molecular mechanisms of viral infection in the human placenta. Pathog. Dis. 2017; 75(7):ftx093.

Delorme-Axford E, Donker RB, Mouillet JF, et al. Human placental trophoblasts confer viral resistance to recipient cells. Proc. Natl. Acad. Sci U S A. 2013; 110(29):12048-12053.

Racicot K, Mor G. Risks associated with viral infections during pregnancy. J. Clin. Invest. 2017; 127(5):1591-1599.

Delorme-Axford E, Bayer A, Sadovsky Y, Coyne CB. Autophagy as a mechanism of antiviral defense at the maternal-fetal interface. Autophagy. 2013; 9(12):2173-4.

Jackson WT. Autophagy as a broad antiviral at the placental interface. Autophagy. 2013; 9(12):1905-7.

Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 2010; 63(6):425-433.

Zorrilla CD, García García I, García Fragoso L, De La Vega A. Zika Virus Infection in Pregnancy: Maternal, Fetal, and Neonatal Considerations. J. Infect. Dis. 2017; 216(suppl_10):S891-S896.

Richard AS, Shim BS, Kwon YC, et al. AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses. Proc. Natl. Acad. Sci. USA. 2017; 114(8):2024-2029.

Duarte G, Moron AF, Timerman A, Fernandes CE, Mariani NC, Almeida Filho GL de et al. Zika Virus Infection in Pregnant Women and Microcephaly. Rev. Bras. Ginecol. Obstet. [Internet]. 2017; 39(5): 235-248.

Yuan S, Luo Q, Zhang ZW, Li ZL. Commentary: Teratogenic effects of the Zika virus and the role of the placenta. Front. Cell. Infect. Microbiol. 2017; 7:62.

Zhang ZW, Li ZL, Yuan S. The Role of Secretory Autophagy in Zika Virus Transfer through the Placental Barrier. Front Cell Infect Microbiol. 2017; 6:206.

Caine EA, Jagger BW, Diamond MS. Animal Models of Zika Virus Infection during Pregnancy. Viruses. 2018; 10(11):598.

Bebell LM, Oduyebo T, Riley LE. Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects. Res. 2017; 109(5):353-362.

Engmann C, Fleming JA, Khan S, et al. Closer and closer? Maternal immunization: current promise, future horizons. J. Perinatol. 2020; 40(6):844-857.

Wiwanitkit V. Ebola virus infection: what should be known? N. Am. J. Med. Sci. 2014; 6(11):549-552.

Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E. Early immune responses accompanying human asymptomatic Ebola infections. Clin. Exp. Immunol. 2001; 124(3):453-460.

Olgun NS. Viral Infections in Pregnancy: A Focus on Ebola Virus. Curr. Pharm. Des. 2018; 24(9):993-998.

Black BO, Caluwaerts S, Achar J. Ebola viral disease and pregnancy. Obstet. Med. 2015; 8(3):108-113.

Jaan A, Rajnik M. TORCH Complex. [Updated 2020 Jul 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560528/ Jaan A, Rajnik M.

Baquero-Artigao F. Actualización en infecciones herpéticas congénitas y neonatales: infección por citomegalovirus y herpes simple. Rev. Neurol. 2017; 64 (Supl 3): S29-33.

Gaensbauer J, Grubenhoff JA. Neonatal Herpes Simplex Virus Infections: New Data, Old Conundrum. Pediatrics. 2019; 143(4):e20190159.

Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Hum. Reprod. Update. 2016; 22(1):116-133.

Muller WJ, Zheng X. Laboratory Diagnosis of Neonatal Herpes Simplex Virus Infections. J. Clin. Microbiol. 2019; 57(5):e01460-18.

Macedo-da-Silva J, Marinho CRF, Palmisano G, Rosa-Fernandes L. Lights and Shadows of TORCH Infection Proteomics. Genes (Basel). 2020; 11(8):894.

Patel CD, Backes IM, Taylor SA, et al. Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity. Sci. Transl. Med. 2019; 11(487):eaau6039.

Zuo Z, Goel S, Carter JE. Association of cervical cytology and HPV DNA status during pregnancy with placental abnormalities and preterm birth. Am. J. Clin. Pathol. 2011; 136 (2): 260-265

Cho G, Min KJ, Hong HR, et al. High-risk human papillomavirus infection is associated with premature rupture of membranes. BMC Pregnancy Childbirth. 2013; 13:173.

Weyn C, Thomas D, Jani J, et al. Evidence of human papillomavirus in the placenta. J. Infect. Dis. 2011; 203(3):341-343.

Rombaldi RL, Serafini EP, Mandelli J, Zimmermann E, Losquiavo KP. Transplacental transmission of Human Papillomavirus. Virol. J. 2008; 5:106.

Whitley RJ. The use of antiviral drugs during the neonatal period. Clin. Perinatol. 2012; 39(1):69-81.

Olafuyi O, Badhan RKS. Dose Optimization of Chloroquine by Pharmacokinetic Modeling During Pregnancy for the Treatment of Zika Virus Infection. J. Pharm. Sci. 2019; 108(1):661-673.

Dörnemann J, Burzio C, Ronsse A, Sprecher A, De Clerck H, Van Herp M, et al. First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease. J. Infect. Dis. 2017; 215(2): 171–174.

Olgun NS. Viral Infections in Pregnancy: A Focus on Ebola Virus. Curr. Pharm. Des. 2018; 24(9):993-998.

Muller, W. Treatment of perinatal viral infections to improve neurologic outcomes. Pediatr. Res. 2017; 81, 162–169

Rogan SC, Beigi RH. Treatment of Viral Infections During Pregnancy. Clin. Perinatol. 2019; 46(2):235-256

Bailey H, Zash R, Rasi V, Thorne C. HIV treatment in pregnancy. Lancet. HIV. 2018; (8):e457-e467.

Cardenas I, Means RE, Aldo P, et al. Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products elizapredisposing to preterm labor. J. Immunol. 2011; 187(5):2835.

Racicot K, Kwon JY, Aldo P, Silasi M, Mor G. Understanding the complexity of the immune system during pregnancy. Am. J. Reprod. Immunol. 2014; 72(2):107-116.

Published
2022-06-05
How to Cite
Ortiz, M. I., Romero Juárez , G. C., & Muñoz Pérez , V. M. (2022). Mechanisms of infection and fetal adverse effects of Zika virus, Ebola virus, Herpes Simplex virus and Human Papillomavirus infection during pregnancy. Educación Y Salud Boletín Científico Instituto De Ciencias De La Salud Universidad Autónoma Del Estado De Hidalgo, 10(20), 211-222. https://doi.org/10.29057/icsa.v10i20.7574

Most read articles by the same author(s)

1 2 > >>